Literature DB >> 28215173

CXCR4-targeted Nanoparticles Reduce Cell Viability, Induce Apoptosis and Inhibit SDF-1α Induced BT-549-Luc Cell Migration In Vitro.

Chuda Chittasupho1, Prartana Kewsuwan2, Takashi Murakami3.   

Abstract

BACKGROUND: CXCR4 possesses a critical role in several intracellular events such as chemotaxis, invasion and adhesion, which are associated with metastasis of cancer cell.
OBJECTIVE: In this study, CXCR4 targeted polymeric nanoparticle was developed for delivering cytotoxic drug and blocking the chemokine induced migration of cells expressing CXCR4.
METHOD: A peptide which was a linear form of CXCR4 antagonist (LFC131) was attached to PLGA nanoparticles (LFC131-NPs) and PLGA nanoparticles encapsulating DOX (LFC131-DOX-NPs). The cellular binding and internalization of LFC131-DOX-NPs were investigated.
RESULTS: The binding and internalization of LFC131-DOX-NPs were higher and more rapidly compared to unconjugated NPs. LFC131-NPs blocked SDF-1α induced migration of BT-549-Luc cells. MTT assays demonstrated that LFC131-NPs and LFC131-DOX-NPs decreased cell viability in a dose dependent manner in 24, 72 and 120 h incubation.
CONCLUSION: A treatment concept of blocking breast cancer cell migration from interaction with SDF- 1α by using LFC131-NPs and then attacking breast cancer cells with doxorubicin might increase the efficacy of current breast cancer treatment. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Breast cancer; CXCR4; LFC131; PLGA; metastasis; nanoparticle

Mesh:

Substances:

Year:  2017        PMID: 28215173     DOI: 10.2174/1567201814666170216130448

Source DB:  PubMed          Journal:  Curr Drug Deliv        ISSN: 1567-2018            Impact factor:   2.565


  3 in total

1.  Effects of Quercetin and Curcumin Combination on Antibacterial, Antioxidant, In Vitro Wound Healing and Migration of Human Dermal Fibroblast Cells.

Authors:  Chuda Chittasupho; Amornrat Manthaisong; Siriporn Okonogi; Sarin Tadtong; Weerasak Samee
Journal:  Int J Mol Sci       Date:  2021-12-23       Impact factor: 5.923

Review 2.  Enhancing the therapeutic efficacy of nanoparticles for cancer treatment using versatile targeted strategies.

Authors:  Hailong Tian; Tingting Zhang; Siyuan Qin; Zhao Huang; Li Zhou; Jiayan Shi; Edouard C Nice; Na Xie; Canhua Huang; Zhisen Shen
Journal:  J Hematol Oncol       Date:  2022-09-12       Impact factor: 23.168

3.  The Potential of Atractylodin-Loaded PLGA Nanoparticles as Chemotherapeutic for Cholangiocarcinoma.

Authors:  Nada Muhamad; Tullayakorn Plengsuriyakarn; Chuda Chittasupho; Kesara Na-Bangchang
Journal:  Asian Pac J Cancer Prev       Date:  2020-04-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.